Missed GME or NVDA? Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
MRM Stock Forecast 2025-2026
$0.80
Current Price
$6.80M
Market Cap
Buy 1
Hold 0
Sell 0
Wall St Analyst Ratings
Distance to MRM Price Targets
+562.8%
To High Target of $5.30
+562.8%
To Median Target of $5.30
+562.8%
To Low Target of $5.30
MRM Price Momentum
-12.1%
1 Week Change
+8.1%
1 Month Change
-86.2%
1 Year Change
-22.3%
Year-to-Date Change
-90.5%
From 52W High of $8.39
+135.3%
From 52W Low of $0.34
📉 MARKET SELLOFF ALERT
10 Quality Stocks Worth Considering Now
Researching Medirom (MRM) after the drop? Our ex-Goldman Sachs analyst reveals if it made our list of 10 oversold quality stocks with strong growth potential.
Get our FREE market selloff report + exclusive analysis on MRM and similar high-potential opportunities.
Latest MRM Stock Price Targets & Analyst Predictions
Wall Street analysts covering MRM have a bullish consensus with a median price target of $5.30 (ranging from $5.30 to $5.30). Currently trading at $0.80, the median forecast implies a 562.8% upside. This outlook is supported by 1 Buy, 0 Hold, and 0 Sell ratings.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
MRM Analyst Ratings
1
Buy
0
Hold
0
Sell
MRM Price Target Range
Low
$5.30
Average
$5.30
High
$5.30
Current: $0.80
Latest MRM Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for MRM.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|
Medirom Healthcare Technologies Inc. (MRM) Competitors
The following stocks are similar to Medirom based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Medirom Healthcare Technologies Inc. (MRM) Financial Data
Medirom Healthcare Technologies Inc. has a market capitalization of $6.80M with a P/E ratio of 4.3x. The company generates $56.73M in trailing twelve-month revenue with a 1.8% profit margin.
Revenue growth is +31.2% quarter-over-quarter, while maintaining an operating margin of +13.3% and return on equity of +23.0%.
Valuation Metrics
Market Cap
$6.80M
Enterprise Value
$25.22M
P/E Ratio
4.3x
PEG Ratio
0.0x
Price/Sales
0.0x
Growth & Margins
Revenue Growth (YoY)
+31.2%
Gross Margin
N/A
Operating Margin
+13.3%
Net Margin
+1.8%
EPS Growth
+55.4%
Financial Health
Cash/Price Ratio
+5,210.7%
Current Ratio
0.6x
Debt/Equity
400.5x
ROE
+23.0%
ROA
+0.0%
💰 DON'T MISS THIS OPPORTUNITY
Get All 10 Quality Stocks For This Market Selloff
Still researching investments after the market drop? Our ex-Goldman Sachs analyst has already identified the 10 highest-quality oversold stocks with strong fundamentals and upside potential.
Why spend hours researching when we've already done the work? Get instant access to our complete market selloff analysis.
Medirom Healthcare Technologies Inc. (MRM) Business Model
About Medirom Healthcare Technologies Inc.
What They Do
Provides wellness and alternative health services.
Business Model
Medirom Healthcare Technologies Inc. operates wellness salons under the 'Re.Ra.Ku' brand, generating revenue through bodywork therapies and lifestyle consultations. The company also develops digital healthcare technologies that enhance their service offerings and improve lifestyle tracking for clients.
Additional Information
Medirom is well-positioned in the Japanese healthcare market, combining traditional services with innovative technology to meet the growing demand for wellness solutions. Their commitment to sustainability and health trends makes them a key player in the industry.
Company Information
Sector
Consumer Cyclical
Industry
Personal Services
Employees
334
CEO
Mr. Kouji Eguchi
Country
Japan
IPO Year
N/A
Website
medirom.co.jpMedirom Healthcare Technologies Inc. (MRM) Latest News & Analysis
Latest News
Quick Summary
MEDIROM Healthcare Technologies Inc. secured a JPY350 million (approx. $2.4 million) unsecured short-term loan. JPY200 million will repay debt, with the remainder for working capital and development. Interest rate is 1.875%.
Why It Matters
MEDIROM's new loan indicates financial maneuvering to manage debt and support product development, affecting liquidity and growth potential, which can influence investor sentiment and stock performance.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM) reports that Chief Business Officer Yasuhiro Hayami has invested again in Mother Labs' Series A financing, valuing it at JPY9 billion (approx. US$60 million).
Why It Matters
Yasuhiro Hayami's additional investment signals confidence in Mother Labs' growth, potentially boosting investor sentiment and impacting MEDIROM's stock performance positively.
Source: GlobeNewsWire
Market Sentiment:
Neutral
MEDIROM Healthcare Technologies Inc. Announces December 2024 Key Performance Indicators (KPIs)
3 months ago
Quick Summary
The company served 80,764 customers, achieving sales of JPY 7,384 per customer, with a repeat customer ratio of 77.6%.
Why It Matters
High customer numbers and a strong repeat ratio indicate robust demand and customer loyalty, suggesting potential revenue stability and growth for the company.
Source: GlobeNewsWire
Market Sentiment:
Neutral
MEDIROM MOTHER Labs Provides MOTHER Bracelet®︎ Device and Remote Health Monitoring System, REMONY, to TOPPAN Inc.
3 months ago
Quick Summary
MEDIROM Healthcare (NASDAQ: MRM) announced its subsidiary, MOTHER Labs, is supplying its remote health monitoring system and smart tracker to TOPPAN Inc. (TSE: 7911).
Why It Matters
The partnership between MEDIROM and TOPPAN enhances MEDIROM's product distribution, potentially increasing revenue and market presence, which could positively impact stock performance.
Source: GlobeNewsWire
Market Sentiment:
Neutral
MEDIROM Healthcare Technologies Inc. Announces November 2024 Key Performance Indicators (KPIs)
4 months ago
Quick Summary
The company served 75,760 customers with sales per customer at JPY 7,055 and a customer repeat ratio of 77.5%.
Why It Matters
Strong customer metrics indicate stable revenue and growth potential. A high repeat ratio suggests customer loyalty, which can lead to increased sales and profitability.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
MEDIROM Healthcare's subsidiary, MEDIROM MOTHER Labs, raised 260.3 million yen (approx. $1.7 million) in Series A financing at a pre-money valuation of 9 billion yen ($58.6 million). The round is ongoing.
Why It Matters
MEDIROM's substantial Series A funding and high pre-money valuation signal investor confidence in its growth potential, which could influence stock performance and attract further investment.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Frequently Asked Questions About MRM Stock
What is Medirom Healthcare Technologies Inc.'s (MRM) stock forecast for 2025?
Based on our analysis of 0 Wall Street analysts, Medirom Healthcare Technologies Inc. (MRM) has a median price target of $5.30. The highest price target is $5.30 and the lowest is $5.30.
Is MRM stock a good investment in 2025?
According to current analyst ratings, MRM has 1 Buy ratings, 0 Hold ratings, and 0 Sell ratings. The stock is currently trading at $0.80. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for MRM stock?
Wall Street analysts predict MRM stock could reach $5.30 in the next 12 months. This represents a 562.8% increase from the current price of $0.80. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Medirom Healthcare Technologies Inc.'s business model?
Medirom Healthcare Technologies Inc. operates wellness salons under the 'Re.Ra.Ku' brand, generating revenue through bodywork therapies and lifestyle consultations. The company also develops digital healthcare technologies that enhance their service offerings and improve lifestyle tracking for clients.
What is the highest forecasted price for MRM Medirom Healthcare Technologies Inc.?
The highest price target for MRM is $5.30 from at , which represents a 562.8% increase from the current price of $0.80.
What is the lowest forecasted price for MRM Medirom Healthcare Technologies Inc.?
The lowest price target for MRM is $5.30 from at , which represents a 562.8% increase from the current price of $0.80.
What is the overall MRM consensus from analysts for Medirom Healthcare Technologies Inc.?
The overall analyst consensus for MRM is bullish. Out of 0 Wall Street analysts, 1 rate it as Buy, 0 as Hold, and 0 as Sell, with a median price target of $5.30.
How accurate are MRM stock price projections?
Stock price projections, including those for Medirom Healthcare Technologies Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: May 16, 2025 4:11 AM UTC